Mavezelimab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Mavezelimab Usage And Synthesis

Uses

Favezelimab (MK-4280) is a humanized anti-LAG-3 monoclonal antibody that blocks the interaction between LAG-3 and its ligand MHC class II. Favezelimab has the potential for colorectal cancer (CRC) research combined with the PD-L1 inhibitor Pembrolizumab.html" class="link-product" target="_blank">Pembrolizumab (HY-P9902)[1][2].

References

[1] Carmen Belli, et al. Targeting Cellular Components of the Tumor Microenvironment in Solid Malignancies. Cancers (Basel). 2022 Sep 1;14(17):4278. DOI:10.3390/cancers14174278
[2] Gareth P. Gregory, et al. Abstract CT106: Anti-LAG-3 antibody MK-4280 in combination with pembrolizumab for the treatment of hematologic malignancies: A Phase I/II study. ?Cancer Res (2019) 79 (13_Supplement): CT106.

Mavezelimab(2231068-83-8)Related Product Information

• Iodine (131I) Apamistamab
• Nerelimomab [usan:inn]
• Lutikizumab
• Tarlatamab
• Concizumab
• Oxelumab
• Roledumab
• Iparomlimab
• Manfidokimab
• Zuberitamab